甲硝唑的致突变性：构效关系 - Suppr

Suppr

超能文献

Mutagenicity of metronidazole: structure-activity relationships.

作者信息

Rosenkranz H S, Speck W T, Stambaugh J E

出版信息

Mutat Res. 1976 Jun;38(3):203-6. doi: 10.1016/0165-1161(76)90191-6.

DOI:10.1016/0165-1161(76)90191-6

PMID:778605

Abstract

摘要

相似文献

Mutagenicity of metronidazole: structure-activity relationships.甲硝唑的致突变性：构效关系

Mutat Res. 1976 Jun;38(3):203-6. doi: 10.1016/0165-1161(76)90191-6.

Mutagenicity of metronidazole: activation by mammalian liver microsomes.甲硝唑的致突变性：由哺乳动物肝脏微粒体激活。

Biochem Biophys Res Commun. 1975 Sep 16;66(2):520-5. doi: 10.1016/0006-291x(75)90541-0.

Studies on the possible mutagenic action of metronidazole.关于甲硝唑可能的诱变作用的研究。

Indian J Exp Biol. 1987 Apr;25(4):240-3.

Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice.检测人体和小鼠体液中甲硝唑和硝唑尼特的诱变活性。

Science. 1975 Jun 13;188(4193):1118-9. doi: 10.1126/science.766186.

Mutagenicity testing of 2,3,7,8-tetrachlordibenzo-p-dioxin in histidine auxotrophs of Salmonella typhimurium.2,3,7,8-四氯二苯并对二恶英在鼠伤寒沙门氏菌组氨酸营养缺陷型中的致突变性测试。

Toxicol Appl Pharmacol. 1981 Jun 15;59(1):125-9. doi: 10.1016/0041-008x(81)90459-2.

Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.用沙门氏菌/哺乳动物微粒体诱变性试验检测致癌物和诱变剂的方法。

Mutat Res. 1975 Dec;31(6):347-64. doi: 10.1016/0165-1161(75)90046-1.

Mutagenicity of streptozotocin and several other nitrosourea compounds in Salmonella typhimurium.链脲佐菌素及其他几种亚硝基脲化合物在鼠伤寒沙门氏菌中的诱变性。

Mutat Res. 1976 Nov;40(4):281-8. doi: 10.1016/0165-1218(76)90026-4.

Mutagenicity of 8-hydroxyquinoline and related compounds in the Salmonella typhimurium bioassay.8-羟基喹啉及相关化合物在鼠伤寒沙门氏菌生物测定中的致突变性。

Biochem Pharmacol. 1976 Jun 1;25(11):1323-8. doi: 10.1016/0006-2952(76)90097-6.

Mutagenic activity of radiosensitizers.放射增敏剂的诱变活性。

Acta Microbiol Pol. 1985;34(2):111-20.

Human blood mutagenicity for Salmonella typhimurium tester strains after oral application of Entizol.口服恩替唑后对鼠伤寒沙门氏菌测试菌株的人体血液致突变性。

Mutat Res. 1980 Apr;77(4):357-60.

引用本文的文献

Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip assay in TK6 cells.使用TGx-DDI转录组生物标志物和高通量彗星芯片分析法在TK6细胞中对三种抗感染药物进行综合遗传毒性测试。

Front Toxicol. 2022 Sep 23;4:991590. doi: 10.3389/ftox.2022.991590. eCollection 2022.

A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests.一种基于DNA损伤与细菌诱变性试验相结合预测抗寄生虫药物致癌性的新策略。

Front Public Health. 2017 Nov 9;5:288. doi: 10.3389/fpubh.2017.00288. eCollection 2017.

Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group.硝基咪唑类药物的遗传毒性和致突变性研究：揭开与硝基的关键关系之谜

Mem Inst Oswaldo Cruz. 2015 Jun;110(4):492-9. doi: 10.1590/0074-02760140248. Epub 2015 May 26.

Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.三种市售硝基杂环药物的遗传毒性再评估：硝呋替莫、苯硝唑和甲硝唑。

J Parasitol Res. 2009;2009:463575. doi: 10.1155/2009/463575. Epub 2009 Oct 21.

Mammalian spot test with moxnidazole, a 5-nitroimidazole.

Experientia. 1978 Apr 15;34(4):500-1. doi: 10.1007/BF01935953.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验